Literature DB >> 12624610

Sagittal abdominal diameter is associated with insulin sensitivity in Chinese hypertensive patients and their siblings.

C-M Hwu1, C-F Hsiao, W H H Sheu, D Pei, T-Y Tai, T Quertermous, B Rodriguez, R Pratt, Y-D I Chen, L-T Ho.   

Abstract

The purpose of the study is to observe the relation between anthropometric measurements, focusing on sagittal abdominal diameter (SAD), and insulin sensitivity indices in Chinese hypertensive patients and their siblings. In total, 907 participants, 537 hypertensive and 370 nonhypertensive, from 311 Taiwanese families were drawn from the Stanford Asia and Pacific Program for Hypertension and Insulin Resistance for the study. The participants received anthropometric measurements and 75-g oral glucose tolerance tests after an overnight fast. Fasting insulin, homeostasis model assessment for insulin resistance (HOMA-IR), and the insulin sensitivity index ISI(0,120) were chosen as surrogate measures of insulin sensitivity. In addition to Pearson and partial correlations, we used generalized estimating equations (GEEs) to examine the association between anthropometric measurements and insulin sensitivity indices. A small deviance in the GEEs indicates the goodness of model fit, irrespective of the independence among variables. The hypertensive patients were older in age, wider in waist circumference (WC), larger in body mass index (BMI) and SAD, and more insulin resistant than the nonhypertensive counterparts. The logarithmic transformation of fasting insulin, HOMA-IR, and ISI(0,120) significantly correlated with SAD, WC, and BMI before and after adjustments for age and sex. The deviances of SAD in the GEEs were similar to those of WC in all subjects, while BMI had smaller deviances than SAD and WC in the hypertensive patients. Our results suggest that the performance of SAD in predicting insulin sensitivity is comparable with WC in Chinese hypertensive patients and their siblings. BMI, however, seems to have better association with insulin sensitivity than SAD and WC in the patients with hypertension.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12624610     DOI: 10.1038/sj.jhh.1001532

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  5 in total

1.  Sagittal Abdominal Diameter as a Surrogate Marker of Insulin Resistance in an Admixtured Population--Brazilian Metabolic Syndrome Study (BRAMS).

Authors:  Ana Carolina J Vasques; Roberta S L Cassani; Adriana C e Forti; Brunna S Vilela; José Carlos Pareja; Marcos Antonio Tambascia; Bruno Geloneze
Journal:  PLoS One       Date:  2015-05-07       Impact factor: 3.240

2.  Sagittal abdominal diameter as a marker of inflammation and insulin resistance among immigrant women from the Middle East and native Swedish women: a cross-sectional study.

Authors:  Helena Petersson; Achraf Daryani; Ulf Risérus
Journal:  Cardiovasc Diabetol       Date:  2007-03-28       Impact factor: 9.951

3.  Endothelin Type A Receptor Genotype is a Determinant of Quantitative Traits of Metabolic Syndrome in Asian Hypertensive Families: A SAPPHIRe Study.

Authors:  Low-Tone Ho; Yung-Pei Hsu; Chin-Fu Hsiao; Chih-Tai Ting; Kuang-Chung Shih; Lee-Ming Chuang; Kamal Masaki; John Grove; Thomas Quertermous; Chi-Chung Juan; Ming-Wei Lin; Shu-Chiung Chiang; Yii-Der I Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2013-11-28       Impact factor: 5.555

4.  Sagittal abdominal diameter is an independent predictor of all-cause and cardiovascular mortality in incident peritoneal dialysis patients.

Authors:  Mi Jung Lee; Dong Ho Shin; Seung Jun Kim; Dong Eun Yoo; Kwang Il Ko; Hyang Mo Koo; Chan Ho Kim; Fa Mee Doh; Hyung Jung Oh; Jung Tak Park; Seung Hyeok Han; Tae-Hyun Yoo; Kyu Hun Choi; Shin-Wook Kang
Journal:  PLoS One       Date:  2013-10-22       Impact factor: 3.240

5.  Sagittal Abdominal Diameter, Waist Circumference, and BMI as Predictors of Multiple Measures of Glucose Metabolism: An NHANES Investigation of US Adults.

Authors:  Shelby A Firouzi; Larry A Tucker; James D LeCheminant; Bruce W Bailey
Journal:  J Diabetes Res       Date:  2018-06-19       Impact factor: 4.011

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.